A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint

DOI: 10.1080/2162402X.2018.1466016

Keywords: bispecific antibody, EGFR, immunotherapy, PD-L1

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text